Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

Abstract Background Antithrombotic guidance statements for hospitalized patients with coronavirus disease 2019 (COVID‐19) suggest a universal thromboprophylactic strategy with potential to escalate doses in high‐risk patients. To date, no clear approach exists to discriminate patients at high risk f...

Descrición completa

Detalles Bibliográficos

Principais autores:	Alex C. Spyropoulos, Stuart L. Cohen, Eugenia Gianos, Nina Kohn, Dimitrios Giannis, Saurav Chatterjee, Mark Goldin, Marty Lesser, Kevin Coppa, Jamie S. Hirsch, Thomas McGinn, Matthew A. Barish, the COVID‐19 Consortium Group
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2021-02-01
Series:	Research and Practice in Thrombosis and Haemostasis
Assuntos:	COVID‐19 hospitalized patients risk assessment thromboembolism thrombosis
Acceso en liña:	https://doi.org/10.1002/rth2.12486
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!